Trial Profile

A phase III registrational trial of ART27.13 for the treatment of anorexia

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 05 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ART 2713 (Primary)
Indications Anorexia
Focus Registrational; Therapeutic Use

Most Recent Events

31 Oct 2025 According to an Artelo Bioscience media release, the company does not anticipate the need to internally fund a phase 3 trial and believes that pursuing a licensing transaction represents the most value-accretive path forward for shareholders.
31 Oct 2025 New trial record
02 Sep 2025 According to a Artelo Biosciences media release, company plans a phase III registrational trial for Anorexia.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com